Sanofi says application for new diabetes drug under FDA review

PARIS (Reuters) - European pharmaceuticals group Sanofi on Tuesday said its application for review for its new drug, lixisenatide, a diabetes treatment, had been accepted by the U.S. Food and Drug Administration. (Reporting by Astrid Wendlandt)